EXECUTIVE HEALTH LIMITEDActive
Key figures
Ratios
2024/25Balance sheet structure
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | 1,096,816 |
| Profit for the year | — | — | — | — | 2,752 |
| Cash at bank and in hand | 3,855 | 405 | 3,282 | 2,096 | 2,246 |
| Total assets | — | — | — | 119,881 | 422,589 |
| Total liabilities | 3,928 | 0 | 2,336 | 120,990 | 423,333 |
| Net assets / total equity | -73 | 405 | 946 | 3,496 | 744 |
| Average number of employees | 0 | 0 | 0 | 0 | 43 |
| Average pay (per year) | — | — | — | — | 14,966 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025Principal activity of the company during the financial year was of 86101 - Hospital activities 86210 - General medical practice activities
As described in the company's latest filed accounts.
Summary: EXECUTIVE HEALTH LIMITED
Company
EXECUTIVE HEALTH LIMITED is a private limited company registered with Companies House under company number 10640329. It was incorporated on 27 Feb 2017. Its status is active. The registered office is in Coventry (CV6). Its nature of business (SIC 2007) is hospital activities (86101), general medical practice activities (86210).
Accounts
The latest accounts in the database are for 2024/25 (period ending 28 Feb 2025); the company files small company accounts (filleted). Turnover was £1,096,816. Profit for the year was £2,752. Net assets were £744, down 78.7% on the previous year. Cash at bank and in hand was £2,246. Total assets were £422,589 and total liabilities £423,333. The company had an average of 43 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 30 Nov 2026. The next confirmation statement is due by 12 Mar 2027.